These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 338900)

  • 1. Studies of antitumor agents. 1. Resolution of racemic 1-(tetrahydro-2-furanyl)-k-fluorouracil into the R and S isomers and examination of the biological activities of the isomers.
    Yasumoto M; Moriyama A; Unemi N; Hashimoto S; Suzue T
    J Med Chem; 1977 Dec; 20(12):1592-4. PubMed ID: 338900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on antitumor agents, 2. Syntheses and antitumor activities of 1-(tetrahydro-2-furanyl)-5-fluorouracil and 1,3-bis(tetrahydro-2-furanyl)-5-fluorouracil.
    Yasumoto M; Yamawaki I; Marunaka T; Hashimoto S
    J Med Chem; 1978 Aug; 21(8):738-41. PubMed ID: 357721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective metabolism of ftorafur (R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil).
    Au JL; Sadée W
    Cancer Chemother Pharmacol; 1981; 7(1):55-9. PubMed ID: 6804104
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and biological activities of ftorafur metabolites. 3'- and 4'-hydroxyftorafur.
    Lin AJ; Benjamin RS; Rao PN; Loo TL
    J Med Chem; 1979 Sep; 22(9):1096-100. PubMed ID: 385879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies to increase the antitumor activity of 1-(tetrahydro-2-furanyl)-5-fluorouracil and its metabolic aspects by combined administration with L-cysteine.
    Kawabata N; Sugiyama S; Kuwamura T; Satoh T; Kitagawa H
    Jpn J Pharmacol; 1983 Aug; 33(4):735-47. PubMed ID: 6415326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic activation of ftorafur [R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil]: the microsomal oxidative pathway.
    El Sayed YM; Sadée W
    Biochem Pharmacol; 1982 Sep; 31(18):3006-8. PubMed ID: 6814451
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolism, antitumor activity, and acute toxicity of 5-fluoro-1,3-bis(tetrahydro-2-furanyl)-2,4-pyrimidinedione by oral administration to animals.
    Fujii S; Nakamura Y; Takeda S; Morita K; Sato T; Marunaka T; Kawaguchi Y; Unemi N
    Gan; 1980 Feb; 71(1):30-44. PubMed ID: 6769737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of metabolites of 1-(tetrahydro-2-furanyl)-5-fluorouracil (FT-207) formed in vitro by rat liver microsomes.
    Marunaka T; Minami Y; Umeno Y; Yasuda A; Sato T; Fujii S
    Chem Pharm Bull (Tokyo); 1980 Jun; 28(6):1795-80. PubMed ID: 6773678
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydroxylated metabolies of R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil (Ftorafur) in rats and rabbits.
    Wu AT; Au JL; Sadée W
    Cancer Res; 1978 Jan; 38(1):210-4. PubMed ID: 338145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition and metabolism of 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) in humans.
    Benvenuto JA; Lu K; Hall SW; Benjamin RS; Loo TL
    Cancer Res; 1978 Nov; 38(11 Pt 1):3867-70. PubMed ID: 359130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P-450-dependent oxidative cleavage of 1-(tetrahydro-2-furanyl)-5-fluorouracil to 5-fluorouracil.
    Kawata S; Minami Y; Tarui S; Marunaka T; Okamoto M; Yamano T
    Jpn J Pharmacol; 1984 Sep; 36(1):43-9. PubMed ID: 6438379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on tetrahydrofuranyl-5-fluorouracils. 2. NMR studies of 1-(tetrahydro-2-furanyl)-, 3-(tetrahydro-2-furanyl)-, and 1,3-bis(tetrahydro-2-furanyl)-5-fluorouracils.
    Yasumoto M; Ueda S; Yamashita J; Hashimoto S
    Nucleic Acids Symp Ser; 1979; (6):s85-8. PubMed ID: 121157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacology of ftorafur (R, S-1-(tetrahydro-2-furanyl)-5-fluorouracil.
    Au JL; Sadée W
    Recent Results Cancer Res; 1981; 76():100-14. PubMed ID: 6785848
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism of 1,3-bis(tetrahydro-2-furanyl)-5-fluorouracil in mice.
    Fujimoto S; Ishigami H; Minami T; Miyazaki M; Itoh K; Kimura K
    J Natl Cancer Inst; 1979 Aug; 63(2):465-8. PubMed ID: 379401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic activation of R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) to 5-fluorouracil by soluble enzymes.
    El Sayed YM; Sadée W
    Cancer Res; 1983 Sep; 43(9):4039-44. PubMed ID: 6409396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Invention of a tumor-selective 5-fluorouracil derivative named S-1 by biochemical modulation of 5-fluorouracil].
    Shirasaka T; Shimamoto Y; Kato T; Fukushima M
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):371-84. PubMed ID: 9492831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Ftorafue [R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil] to 5-fluorouracil and gamma-butyrolactone.
    Au JL; Sadée W
    Cancer Res; 1980 Aug; 40(8 Pt 1):2814-9. PubMed ID: 6771006
    [No Abstract]   [Full Text] [Related]  

  • 18. Stereoselective metabolism and pharmacokinetics of tegafur.
    Damle BD; Narasimhan NI; Kaul S
    Biopharm Drug Dispos; 2001 Mar; 22(2):45-52. PubMed ID: 11745907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence determination of 5-fluorouracil and 1-(tetrahydro-2-furanyl)-5-fluorouracil in blood serum by high-performance liquid chromatography.
    Iwamoto M; Yoshida S; Hirose S
    J Chromatogr; 1984 Sep; 310(1):151-7. PubMed ID: 6438145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of cytochromes P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes.
    Komatsu T; Yamazaki H; Shimada N; Nakajima M; Yokoi T
    Drug Metab Dispos; 2000 Dec; 28(12):1457-63. PubMed ID: 11095583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.